Revelation Biosciences, Inc.

REVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Feb 23, 2021 CURRENT REPORT
SC 13G/A Feb 16, 2021
SC 13G Feb 10, 2021 PAIC 13G
SC 13G Feb 10, 2021 FORM SC 13G
SC 13G/A Feb 8, 2021 SC 13G/A
SC 13G/A Feb 5, 2021
4 Dec 31, 2020
4 Dec 31, 2020
10-Q Nov 16, 2020 QUARTERLY REPORT
4 Nov 12, 2020 PRIMARY DOCUMENT
SC 13G Nov 10, 2020
8-K Nov 10, 2020 FORM 8-K
4 Oct 21, 2020
3 Oct 21, 2020 OWNERSHIP DOCUMENT
4 Oct 20, 2020
8-K Oct 19, 2020 CURRENT REPORT
4 Oct 19, 2020 PRIMARY DOCUMENT
3 Oct 19, 2020 PRIMARY DOCUMENT
SC 13G Oct 16, 2020
SC 13G Oct 16, 2020 SC 13G
8-K Oct 13, 2020 CURRENT REPORT
3 Oct 13, 2020
424B4 Oct 13, 2020 PROSPECTUS
3 Oct 9, 2020
3 Oct 9, 2020
← Newer Page 15 of 16 · 387 filings Older →